• An audit of the management of elderly patients with glioblastoma in the UK: have recent trial results changed treatment?

      Chong, MY; Lorimer, CF; Mehta, Shaveta; Ibrahim, Ehab; Brock, J; McBain, Catherine A; McLoone, P; Chalmers, AJ; NHS Greater Glasgow & Clyde, Glasgow, Scotland (2019)
      Aim: We investigated uptake of short-course chemo-radiotherapy and compared outcomes with other treatment schedules in elderly patients with glioblastoma (GBM). Methods: Patients aged 65 or over with a diagnosis of GBM were identified from an 18-month period from three centers in the UK. The primary end point of this study was overall survival from the date of diagnosis. Results: The analysis included 210 patients. Overall median survival was 5.0 months. Approximately 31.9% of patients received combined chemoradiation; multivariate analysis showed that patients who received standard chemoradiation were at a reduced risk of death than those receiving hypofractionated chemoradiation. Discussion: In this retrospective study, patients treated with standard chemoradiation experienced better outcomes than patients receiving hypofractionated chemoradiation. Patient selection likely contributed to these findings.
    • The case study masterclass. Case 53 answers: management of malignant bowel obstruction.

      Ibrahim, Ehab; Willard, Carole; Palliative Care and Support Department, The Christie NHS Foundation Trust, Manchester (2011)
    • Outcome of solitary plasmacytoma.

      Ibrahim, Ehab; Harris, Maggie A; The Christie NHS Foundation Trust, Manchester, UK (2016)